Researchers from the Oxford Vaccine Group's Com-COV vaccine trial discovered that adults were more likely to suffer from mild to moderate side effects after mixing doses of the AstraZeneca and Pfizer..
Credit: Cover Video STUDIO Duration: 01:22Published